VIEW
IN BROWSER
EDITOR'S
NOTE: Big4Bio
newsletters will not be published from Sept
4th-7th; they will resume distribution on Tuesday,
Sept 8th.
|
 |
| SEPTEMBER
3, 2026 |
| Regional
intelligence on Drugs, Diagnostics,
Devices & Digital Health |
|
|
|
* may need subscription to view |
 |
BIG4BIO
CEO WEEKLY Q&A:
James Mackay, Ph.D., President & CEO,
Crystalys Therapeutics |
| In this
Q&A, Mackay discusses the clinical
setback that led him to found Crystalys,
what sets dotinurad apart from earlier
gout therapies, the company's recent
milestones, and where he sees the company
heading over the next three years. More |
|
|
- Armata
Pharmaceuticals: New Publication That
Advances Understanding of Phage Biology to
Support Development of Next-Generation
Antibacterials More
- Eledon
Pharmaceuticals: Islet Cell Transplantation
IND Submission, First Patients Enrolled in
Multiple Transplant Programs, and Reaffirms
Plan to Initiate Phase 3 Kidney
Transplantation Trial in Fourth Quarter 2026
More
- EntroGen:
Launches DPYD Genotyping Kit More
- Himplant:
Receives ANMAT Approval, Paving the Way for
Launch in Argentina More
- Prolacta
Bioscience: 20 Years Advancing NICU Nutrition
and Improving Outcomes for Babies Under 3
Pounds More
- TLI:
Dr. Timothy Hatlen Contributes to Positive
Phase 3 Hepatitis C Trial Results More
- UCI:
Stopping Chronic Pain Before It Starts More
- UCLA
Health: Dr. Daniel Low Honored With ASTRO Gold
Medal for Contributions to Radiation Oncology
More
|
|
- LSN:
Hot Investor Mandates (Updated 9/1) More
- Next
Biotech Boom May Be Cancer Vaccines: Watch
These ETFs More
- The
Oral PCSK9 Inhibitor Market Enters High-Growth
Phase Owing to the Approval of Merck's
LIPFENDRA and the Emergence of Oral PCSK9
Inhibitor Drugs, Including, AstraZeneca's
AZD0780, Aqur's AQR-008, and Others |
DelveInsight More
|
|
- Big4Bio CEO Weekly Q&A: James
Mackay, Ph.D., President & CEO,
Crystalys Therapeutics More
- Biotech
& Pharma Updates | September 2, 2026 More
- Subscribe to LifeSci Startup for
Updates on US Startups More
|
|
-
|
| Life
Sciences Talent and Consulting
Strategist George Quinn Named
Partner, Fractional Talent at
Slone Partners |
|
Learn More
→ |
|
|
- Fierce Biotech Layoff Tracker 2026: TScan
Telegraphs 75% Headcount Drop; ArsenalBio
Winnows Down Workforce More
- ICYMI: Aspen Medical Products Strengthens
Executive Leadership Team With Appointment of
Steve Paul as President More
- ICYMI: The Lundquist Institute - Meredith
Johnston Joins as Chief Development Officer More
- OPPORTUNITY: Head of Marketing &
Communications - Remote More
- OPPORTUNITY: Vice President, Business
Development - Remote More
- Slone Partners: Behind the
Search’: A Conversation with George Quinn,
Partner, Fractional Talent More
- Slone Partners: Fractional
Leadership in Biotech and Life Sciences:
When it Works and Why More
- Slone Partners: ICYMI - How to Keep Your
Highest Performers Engaged More
- STAAR Surgical: Names Medtech
Innovator and Platform Builder Ben Park as
Chief Technology Officer More
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: Los Angeles Life Science
Company Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:Los
Angeles, all rights reserved
2026
© 2026
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
